Endocrine comorbidities in patients with PsA compared with controls (univariable analysis). Values are n (%) unless otherwise specified.
| Comorbidities | PsA, n = 3161 | Control Group, n = 31,610 | Univariable Analysis | ||
|---|---|---|---|---|---|
| OR | 95% CI | p | |||
| Diabetes mellitus | 881 (27.9) | 6545 (20.7) | 1.56 | 1.43–1.70 | < 0.0001 |
| Diabetes insipidus | 3 (0.1) | 12 (0.04) | 2.50 | 0.71–8.86 | NS |
| Hypothyroidism | 403 (12.7) | 2705 (8.6) | 1.62 | 1.44–1.81 | < 0.0001 |
| Hyperthyroidism | 46 (1.5) | 454 (1.4) | 1.01 | 0.75–1.38 | NS |
| Hypo/hyperparathyroidism | 24 (0.8) | 184 (0.6) | 1.30 | 0.85–2.00 | NS |
| Acromegaly | 0 (0) | 5 (0.02) | NS | ||
| Hyperprolactinemia | 2 (0.1) | 52 (0.2) | 0.38 | 0.09–1.58 | NS |
| Osteoporosis | 416 (13.2) | 2867 (9.1) | 1.69 | 1.49–1.92 | < 0.0001 |
| Cushing disease | 9 (0.3) | 17 (0.1) | 5.30 | 2.36–11.90 | < 0.0001 |
| Addison disease | 4 (0.1) | 13 (0.04) | 3.33 | 1.07–10.33 | 0.037 |
PsA: psoriatic arthritis; NS: not significant.